Alpha Cognition (XCNQ:ACOG) Accounts Payable & Accrued Expense : C$0.87 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Alpha Cognition Accounts Payable & Accrued Expense?

Alpha Cognition's quarterly accounts payable & accrued expense declined from Sep. 2023 (C$1.37 Mil) to Dec. 2023 (C$0.81 Mil) but then increased from Dec. 2023 (C$0.81 Mil) to Mar. 2024 (C$0.87 Mil).

Alpha Cognition's annual accounts payable & accrued expense increased from Dec. 2021 (C$0.93 Mil) to Dec. 2022 (C$3.12 Mil) but then declined from Dec. 2022 (C$3.12 Mil) to Dec. 2023 (C$0.81 Mil).

Alpha Cognition Accounts Payable & Accrued Expense Historical Data

The historical data trend for Alpha Cognition's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Cognition Accounts Payable & Accrued Expense Chart

Alpha Cognition Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

0.28

0.93

3.12

0.81

Alpha Cognition Quarterly Data
	Jan20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial										2.71	0.91	1.37	0.81	0.87

Alpha Cognition Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Alpha Cognition (XCNQ:ACOG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Cognition Inc (XCNQ:ACOG) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ACOGF:USA

Address

301 - 1228 Hamilton Street, Vancouver, BC, CAN, V6B 6L2

Website

https://www.alphacognition.com

Alpha Cognition Inc is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, and Cognitive Impairment with Mild Traumatic Brain Injury (mTBI) for which there are limited or no treatment options. The Company is focused on the development of ALPHA-1062 for the treatment of mild-to-moderate Alzheimer's disease and completed an NDA filing to the FDA in September 2023. The company anticipates an FDA approval in mid-2024. The Company's ALPHA-1062 development program is primarily focused on clinical and regulatory development, Chemistry, Manufacturing and Control (CMC) development, and commercial readiness.

Alpha Cognition (XCNQ:ACOG) Headlines

No Headlines